News

WHO receives vital new funding for the Global Fund

The pledges, amounting to USD 14.02 billion will cover a three-year period (2020-2022) to finance the fight against HIV, TB and malaria.

Read More

Oct 11, 2019

By : Team ABLE

Dr Harsh Vardhan launches WHO India Country Cooperation Strategy 2019–2023

The Country Cooperation Strategy (CCS) provides a strategic roadmap for WHO to work with the Government of India towards achieving its health sector goals

Read More

Oct 10, 2019

By : Team ABLE

Viela Bio, Mitsubishi Tanabe to co-develop, commercialize autoimmune disease drug in Japan and nine Asia regions

Mitsubishi Tanabe will lead the development and commercialization of inebilizumab in Japan, Thailand, South Korea, Indonesia, Vietnam, Malaysia, Philippines, Singapore, and Taiwan.

Read More

Oct 09, 2019

By : By Team ABLE

DBT calls for R &D proposals on Nanotechnology based tools to enhance agricultural productivity

Nanotechnology has huge potential in agricultural practices which is not yet exploited. Hence, DBT has invited R&D proposals in the field of nanotechnology.

Read More

Oct 09, 2019

By : Team ABLE

Biocon and Mylan launch Insulin Glargine biosimilar Semglee in Australia

Insulin glargine is a long-acting basal insulin analogue, given once daily to help control the blood sugar levels of those with diabetes.

Read More

Oct 03, 2019

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights